Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 7/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL491040 | 0.85 | ALOX5 (0.70) | ALOX5CYP3A4TSHRKDM4ESMN1; SMN2 | |
| SCHEMBL11416924 | 0.85 | ALOX5 (0.65) | ALOX5CYP3A4TSHRALDH1A1KDM4E | |
| SCHEMBL1531522 | 0.83 | ALOX5 (1.00) | ALOX5CYP3A4TSHRALDH1A1KDM4E | |
| SCHEMBL30513891 | 0.82 | ALOX5 (0.72) | ALOX5CYP3A4TSHRKDM4ESMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8957363 | 0.81 | ALOX5 (0.96) | ALOX5CYP3A4TSHRALDH1A1KDM4E | |
| SCHEMBL8974891 | 0.81 | L3MBTL1 (0.67) | CYP3A4ALDH1A1KDM4ESMN1; SMN2L3MBTL1 | |
| SCHEMBL6633779 | 0.80 | ALOX5 (0.80) | ALOX5CYP3A4TSHRALDH1A1KDM4E | |
| SCHEMBL13042440 | 0.80 | ALOX5 (0.68) | ALOX5CYP3A4TSHRALDH1A1KDM4E | |
| SCHEMBL11418048 | 0.79 | ALOX5 (0.73) | ALOX5CYP3A4TSHRALDH1A1KDM4E | |
| SCHEMBL19720259 | 0.79 | ALOX5 (0.62) | ALOX5CYP3A4TSHRALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106141-B2 | Cure accelerators for anaerobic curable compositions | HENKEL CORPORATION (US) | 2012-01-31 | — | — | US | disclosed |
| US-20090281335-A1 | Cure Accelerators for Anaerobic Curable Compositions | HENKEL CORPORATION (US) | 2009-11-12 | — | — | US | disclosed |
| US-20090277356-A1 | Cure Accelerators for Anaerobic Curable Compositions | HENKEL CORPORATION (US) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090277356-A1 | Cure Accelerators for Anaerobic Curable Compositions | ACLY, ACAD9, CCNY | ALOX5 903/4885CYP3A4 2198/4885TSHR 4841/4885 |
| US-20090281335-A1 | Cure Accelerators for Anaerobic Curable Compositions | CAT, MRM1, ACLY | ALOX5 1127/4885CYP3A4 2057/4885TSHR 4604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.